You are currently viewing a new version of our website. To view the old version click .

Vaccines, Volume 10, Issue 9

September 2022 - 198 articles

Cover Story: Human papillomavirus (HPV) is the most common sexually transmitted infection and is linked to several cancers. HPV vaccination is a safe and effective strategy to control HPV infection. However, in the US, HPV vaccination rates are suboptimal. More so, the onset of the COVID-19 pandemic disrupted access to preventive services. Provider recommendation is known to be the strongest predictor of vaccination. A population-based survey of providers was conducted to assess the role of recommendations on observed changes in acceptance of HPV vaccination in the context of the COVID-19 pandemic. This study highlights the importance of provider recommendations on HPV vaccination acceptance despite the disruptive effect of the pandemic. Providers should continue to recommend HPV vaccination at every visit to increase uptake. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (198)

  • Article
  • Open Access
6 Citations
3,444 Views
9 Pages

Intranasal Treatment of Ferrets with Inert Bacterial Spores Reduces Disease Caused by a Challenging H7N9 Avian Influenza Virus

  • Joe James,
  • Stephanie M. Meyer,
  • Huynh A. Hong,
  • Chau Dang,
  • Ho T. Y. Linh,
  • William Ferreira,
  • Paidamoyo M. Katsande,
  • Linh Vo,
  • Daniel Hynes and
  • William Love
  • + 2 authors

19 September 2022

Background: Influenza is a respiratory infection that continues to present a major threat to human health, with ~500,000 deaths/year. Continued circulation of epidemic subtypes in humans and animals potentially increases the risk of future pandemics....

  • Brief Report
  • Open Access
1 Citations
3,319 Views
9 Pages

Diplopia, COVID-19 and Vaccination: Results from a Cross-Sectional Study in Croatia

  • Jelena Škunca Herman,
  • Goran Marić,
  • Maja Malenica Ravlić,
  • Lana Knežević,
  • Ivan Jerković,
  • Ena Sušić,
  • Vedrana Marić,
  • Ivanka Petric Vicković,
  • Zoran Vatavuk and
  • Ozren Polašek

19 September 2022

The aim of this study was to explore diplopia as a symptom of undetected COVID-19 infection or as a possible side effect of COVID-19 vaccination. We examined 380 patients with diplopia admitted to the Department of Ophthalmology of the University Hos...

  • Article
  • Open Access
3 Citations
2,575 Views
11 Pages

Bioinformatic Analysis for Mucoepidermoid and Adenoid Cystic Carcinoma of Therapeutic Targets

  • Carla Monserrat Ramírez-Martínez,
  • Luis Fernando Jacinto-Alemán,
  • Luis Pablo Cruz-Hervert,
  • Javier Portilla-Robertson and
  • Elba Rosa Leyva-Huerta

19 September 2022

Salivary gland neoplasms are a heterogeneous neoplasm group, including mucoepidermoid carcinoma (MECa), adenoid cystic carcinoma (AdCC), and many others. Objective: We aimed to identify new critical genes of MECa and AdCC using bioinformatics analysi...

  • Communication
  • Open Access
6 Citations
2,790 Views
8 Pages

18 September 2022

Introduction: While recent years have observed a substantial improvement in vaccination coverage among children in developing countries, many children are still left out and remain unvaccinated. This study analyzes the trend of the prevalence and cha...

  • Review
  • Open Access
7 Citations
2,262 Views
7 Pages

Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control

  • Marie Mura,
  • Fabrice Simon,
  • Vincent Pommier de Santi,
  • Frédéric Tangy and
  • Jean-Nicolas Tournier

18 September 2022

The recent surge of COVID-19 related to the Omicron variant emergence has thrown a harsh light upon epidemic control in the near future. This should lead the scientific and medical community to question the long-term vaccine strategy for SARS-CoV-2 c...

  • Article
  • Open Access
8 Citations
4,246 Views
20 Pages

Comparison of COVID-19 Vaccine Policies in Italy, India, and South Africa

  • Manfei Yang,
  • Leiyu Shi,
  • Haiqian Chen,
  • Xiaohan Wang,
  • Jun Jiao,
  • Meiheng Liu,
  • Junyan Yang and
  • Gang Sun

18 September 2022

(1) Purpose: This study aimed to analyze coronavirus disease 2019 (COVID-19) vaccine policies and their effectiveness in Italy, India, and South Africa to provide empirical experience for vaccination and COVID-19 pandemic control. (2) Methods: The st...

  • Article
  • Open Access
35 Citations
8,494 Views
28 Pages

Coronavirus Disease 2019 (COVID-19) Pandemic across Africa: Current Status of Vaccinations and Implications for the Future

  • Olayinka O. Ogunleye,
  • Brian Godman,
  • Joseph O. Fadare,
  • Steward Mudenda,
  • Adekunle O. Adeoti,
  • Adesola F. Yinka-Ogunleye,
  • Sunday O. Ogundele,
  • Modupe R. Oyawole,
  • Marione Schönfeldt and
  • Wafaa M. Rashed
  • + 33 authors

17 September 2022

The introduction of effective vaccines in December 2020 marked a significant step forward in the global response to COVID-19. Given concerns with access, acceptability, and hesitancy across Africa, there is a need to describe the current status of va...

  • Review
  • Open Access
16 Citations
3,662 Views
30 Pages

Nanoclays: Promising Materials for Vaccinology

  • Dania O. Govea-Alonso,
  • Mariano J. García-Soto,
  • Lourdes Betancourt-Mendiola,
  • Erika Padilla-Ortega,
  • Sergio Rosales-Mendoza and
  • Omar González-Ortega

17 September 2022

Clay materials and nanoclays have gained recent popularity in the vaccinology field, with biocompatibility, simple functionalization, low toxicity, and low-cost as their main attributes. As elements of nanovaccines, halloysite nanotubes (natural), la...

  • Review
  • Open Access
2 Citations
3,672 Views
20 Pages

Design Strategies and Precautions for Using Vaccinia Virus in Tumor Virotherapy

  • Xinjun Liu,
  • Jian Zhao,
  • Xiaopeng Li,
  • Fengxue Lao and
  • Min Fang

17 September 2022

Oncolytic virotherapy has emerged as a novel form of cancer immunotherapy. Oncolytic viruses (OVs) can directly infect and lyse the tumor cells, and modulate the beneficial immune microenvironment. Vaccinia virus (VACV) is a promising oncolytic vecto...

  • Review
  • Open Access
4 Citations
4,738 Views
10 Pages

Human Respiratory Infections in Nigeria: Influenza and the Emergence of SARS-CoV-2 Pandemic

  • Dennis Kabantiyok,
  • Nathaniel Ninyio,
  • Ismaila Shittu,
  • Clement Meseko,
  • Theophilus I. Emeto and
  • Oyelola A. Adegboye

17 September 2022

The increasing outbreak of zoonotic diseases presents challenging times for nations and calls for a renewed effort to disrupt the chain of events that precede it. Nigeria’s response to the 2006 bird flu provided a platform for outbreak response...

of 20

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X